FDA Drug Recalls

Recalls / Class II

Class IID-0242-2022

Product

Tinactin (Tolnaftate 1%) DEODORANT POWDER SPRAY NET WT 133g (4.6 OZ) can, labeled as (a) UPC 3 11017-410-00 4, NDC 11523-4162-1, Product of Finland 86568411; (b) UPC 3 11017 41000 4, NDC 11523-4162-1, Product of Finland 20006105; Dist by: Bayer Healthcare LLC, Whippany, NJ 07981

Brand name
Tinactin
Generic name
Tolnaftate
Active ingredient
Tolnaftate
Route
Topical
NDC
11523-4162
FDA application
M005
Affected lot / code info
Lot # (a) TN004BW, EXP 7/31/2022, (b) TN00678, EXP 8/31/2022; TN00679, EXP 9/30/2022;

Why it was recalled

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Recalling firm

Firm
Bayer Healthcare Pharmaceuticals Inc.
Manufacturer
Bayer HealthCare LLC.
Notification channel
Press Release
Type
Voluntary: Firm initiated
Address
100 Bayer Blvd, N/A, Whippany, New Jersey 07981-1544

Distribution

Quantity
738,432 cans
Distribution pattern
Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.

Timeline

Recall initiated
2021-10-01
FDA classified
2021-11-18
Posted by FDA
2021-11-24
Terminated
2023-06-26
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0242-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Tinactin · FDA Drug Recalls